Concepedia
Statistics
Publications
8
Citations
2.8K
H-Index
Active since
2002
Affiliations
Novartis Institutes for BioMedical Research(Current)
Novartis (Switzerland)
Novartis (United States)
University of Münster
Stephan Bek is an author at Novartis Institutes for BioMedical Research specializing in immunology, inflammation, and life sciences.
Publications per year
2002–2017
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
Wolfgang Hueber, Bruce E. Sands, Steve Lewitzky et al. · Gut · 2012 · 1.5K citations · Full text
Life Sciences, Immunology, Pharmacotherapy +15
Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial
Dominique Baeten, Xenofon Baraliakos, Jürgen Braun et al. · The Lancet · 2013 · 590 citations
Medicine, Clinical Sciences, Immunology +14
In vivo regulation of interleukin 1β in patients with cryopyrin-associated periodic syndromes
Helen J. Lachmann, Philip J. Lowe, Sandra Daniela Felix et al. · The Journal of Experimental Medicine · 2009 · 302 citations
Veterinary Medicine, Immunology, Pathobiology +17
Absolute Quantification of Monoclonal Antibodies in Biofluids by Liquid Chromatography−Tandem Mass Spectrometry
Charlotte Hagman, Darrell Ricke, Stefan Ewert et al. · Analytical Chemistry · 2008 · 114 citations
Pharmacy, Biochemistry, Immunology +17
Protein kinase CKII regulates the interaction of β-catenin withα-catenin and its protein stability
Stephan Bek, Rolf Kemler · Journal of Cell Science · 2002 · 91 citations
Life Sciences, Cell Biology, Molecular Biology +9
1–5 of 8